Background The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in
participants with abnormal glucose metabolism have been linked in previous studies …

Background The atherogenic index of plasma (AIP) can reflect the burden of atherosclerosis.
Hyperglycemia is one of the leading causes of atherosclerosis. However, the relationship …

Background Atherosclerosis is closely linked with glucose metabolism. We aimed to
investigate the role of the atherogenic index of plasma (AIP) in the reversal of prediabetes to …

Abstract Aims Atherogenic Index of Plasma (AIP) has been proposed as a novel marker of
plasma atherogenicity, but its longitudinal predictive value in type 2 diabetes mellitus …

Background The atherogenic index of plasma (AIP) is composed of triglycerides and high-
density lipoprotein cholesterol and is a novel marker for assessing the risk of atherogenicity …

Background Although a great deal of scientific evidence on the epidemiological risk factors
for diabetes and prediabetes has been accumulated, there is still insufficient evidence to …

Background Although there is numerous evidence on the epidemiological risk factors for
insulin resistance (IR)-related metabolic diseases, there is still insufficient evidence to …

Background and aims The atherogenic index of plasma (AIP) is supposed to be associated
with cardiovascular disease (CVD), but there is limited evidence on its longitudinal effect …

Background Previous studies reported the prognostic value of the atherogenic index of
plasma (AIP) in the course of atherosclerosis and other cardiovascular diseases (CVDs) …

Abstract Background The Atherogenic Index of Plasma (AIP) is a newly identified biomarker
associated with lipid metabolism, demonstrating significant prognostic capabilities in …